Skip to main content

Carbetapentane / guaifenesin / pseudoephedrine Pregnancy and Breastfeeding Warnings

Brand names: Exall-D

Carbetapentane / guaifenesin / pseudoephedrine Pregnancy Warnings

Carbetapentane/guaifenesin/pseudoephedrine has been assigned to FDA pregnancy category C. Animal studies have not been reported. There are no controlled data in human pregnancy. The manufacturer recommends that carbetapentane/guaifenesin/pseudoephedrine not be administered to pregnant women.

See references

Carbetapentane / guaifenesin / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of carbetapentane/guaifenesin/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals

References for breastfeeding information

  1. (2009) "Product Information. Exall-D (carbetapentane/guaifenesin/pseudoephedrine)." Hawthorn Pharmaceuticals

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.